GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accounts Payable

Alto Neuroscience (Alto Neuroscience) Accounts Payable : $2.41 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Accounts Payable?

Alto Neuroscience's Accounts Payable for the quarter that ended in Mar. 2024 was $2.41 Mil.

Alto Neuroscience's quarterly Accounts Payable declined from Sep. 2023 ($1.76 Mil) to Dec. 2023 ($1.07 Mil) but then increased from Dec. 2023 ($1.07 Mil) to Mar. 2024 ($2.41 Mil).

Alto Neuroscience's annual Accounts Payable increased from Dec. 2021 ($0.60 Mil) to Dec. 2022 ($1.61 Mil) but then declined from Dec. 2022 ($1.61 Mil) to Dec. 2023 ($1.07 Mil).

Alto Neuroscience Accounts Payable Historical Data

The historical data trend for Alto Neuroscience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Accounts Payable Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
0.60 1.61 1.07

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial 1.61 - 1.76 1.07 2.41

Alto Neuroscience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Alto Neuroscience Accounts Payable Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accounts Payable
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024